Radiotherapeutic Management of Cervical Lymph Node Metastases from an Unknown Primary Site - Experiences from a Large Cohort Treated with Modern Radiation Techniques

Overview

Journal Radiat Oncol

Publisher Biomed Central

Specialties Oncology
Radiology

Date 2020 Apr 16

PMID 32293497

Citations 5

Authors

Tanja Sprave

Alexander Ruhle

Katharina Hees

Tobias Kalckreuth

Vivek Verma

Raluca Stoian

Constantinos Zamboglou

Jens Pfeiffer

Roland Laszig

Andreas Knopf

Anca-Ligia Grosu

Nils H Nicolay

Affiliations

Soon will be listed here.

Abstract

Purpose: To analyze management and outcomes following (chemo)radiation therapy in patients with cervical lymph node metastases from an unknown primary site (CCUP) in a large single-center cohort.

Methods: Between 2008 and 2019, 58 patients with CCUP were treated with (chemo)radiation therapy at the University of Freiburg Medical Center and were included in this analysis. Overall survival (OS), locoregional progression-free survival (PFS) and distant metastasis-free survival (DMFS) were calculated using the Kaplan-Meier method. The use of diagnostic procedures and their impact on oncological outcomes was analyzed by Cox regression, and treatment-related toxicities were quantified.

Results: Median follow-up was 29.9 months (range 4.6-121.9). Twenty-one patients (36.2%) received definitive RT, 35 (60.3%) underwent adjuvant RT, and 2 (3.4%) were treated for oligometastatic disease. Concurrent chemotherapy was prescribed in 40 patients (69.0%). 89.6% of patients completed the prescribed RT, and 65.0% completed the prescribed simultaneous chemotherapy. Locoregional recurrence was observed in 7 patients (12.1%) and distant metastases in 13 cases (22.4%). OS was 81,1, 64.9% and 56,6% after 1, 3 and 5 years, respectively. Univariate analysis of age, gender, extracapsular spread, tumor grading, neck dissection, diagnostic utilization of F-fluorodeoxyglucose positron-emission tomography and concomitant chemotherapy showed no effect on OS (p > 0.05 for all), while smoking was significantly associated with decreased survival (p < 0.05). There was a trend towards impaired OS for patients with advanced nodal status (pN3) (p = 0.07). Three patients (5.2%) experienced grade 3 radiation dermatitis, and 12 (22.4%) developed grade 3 and 1 (1.7%) grade 4 mucositis.

Conclusions: RT of the panpharynx and cervical lymph nodes with concurrent chemotherapy in case of risk factors demonstrated good locoregional control, but the metachronous occurrence of distant metastases limited survival and must be further addressed.

Citing Articles

Head and Neck Cancer of Unknown Primary: A Multicenter Retrospective Cohort study in Northern Thailand, an Endemic Nasopharyngeal Cancer Area.

Sittitrai P, Ruenmarkkaew D, Chitapanarux I, Muangwong P, Kangsadarnwiroon K, Benjawongsatien R Asian Pac J Cancer Prev. 2024; 25(2):699-708.

PMID: 38415558 PMC: 11077134. DOI: 10.31557/APJCP.2024.25.2.699.

Factors influencing the 5-year survival rate of oral cancer patients in the Mongolian population: a retrospective cohort study.

Davaatsend O, Altannamar M, Batbayar B, Jagdagsuren U Front Oral Health. 2024; 4:1292720.

PMID: 38161344 PMC: 10755018. DOI: 10.3389/froh.2023.1292720.

Comparison of PD-L1 expression in squamous cell cancer of unknown primary and oropharyngeal squamous cell carcinoma.

Schmidl B, Vossenkamper K, Stark L, Boxberg M, Stogbauer F, Feigl K Eur Arch Otorhinolaryngol. 2022; 280(4):1991-1997.

PMID: 36576530 PMC: 9988788. DOI: 10.1007/s00405-022-07775-z.

Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor.

Eilsberger F, Noltenius F, Librizzi D, Wessendorf J, Luster M, Hoch S Biomedicines. 2022; 10(9).

PMID: 36140197 PMC: 9495705. DOI: 10.3390/biomedicines10092095.

Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients.

Wichmann G, Willner M, Kuhnt T, Kluge R, Gradistanac T, Wald T Front Oncol. 2021; 11:682088.

PMID: 34026656 PMC: 8138574. DOI: 10.3389/fonc.2021.682088.

References

Reddy S, Marks J . Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat Oncol Biol Phys. 1997; 37(4):797-802. DOI: 10.1016/s0360-3016(97)00025-4. View

Nieder C, Gregoire V, Ang K . Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple?. Int J Radiat Oncol Biol Phys. 2001; 50(3):727-33. DOI: 10.1016/s0360-3016(01)01462-6. View

Beldi D, Jereczek-Fossa B, dOnofrio A, Gambaro G, Fiore M, Pia F . Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients. Int J Radiat Oncol Biol Phys. 2007; 69(4):1051-8. DOI: 10.1016/j.ijrobp.2007.04.039. View

Hauswald H, Lindel K, Rochet N, Debus J, Harms W . Surgery with complete resection improves survival in radiooncologically treated patients with cervical lymph node metastases from cancer of unknown primary. Strahlenther Onkol. 2008; 184(3):150-6. DOI: 10.1007/s00066-008-1765-y. View

Perkins S, Spencer C, Chernock R, Haughey B, Nussenbaum B, Adkins D . Radiotherapeutic management of cervical lymph node metastases from an unknown primary site. Arch Otolaryngol Head Neck Surg. 2012; 138(7):656-61. DOI: 10.1001/archoto.2012.1110. View

Pfeiffer J, Kayser L, Ridder G . Minimal-invasive core needle biopsy of head and neck malignancies: clinical evaluation for radiation oncology. Radiother Oncol. 2008; 90(2):202-7. DOI: 10.1016/j.radonc.2008.10.018. View

Cooper J, Pajak T, Forastiere A, Jacobs J, Campbell B, Saxman S . Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004; 350(19):1937-44. DOI: 10.1056/NEJMoa032646. View

Pavlidis N, Briasoulis E, Hainsworth J, Greco F . Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003; 39(14):1990-2005. DOI: 10.1016/s0959-8049(03)00547-1. View

Dixon P, Au M, Hosni A, Perez-Ordonez B, Weinreb I, Xu W . Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma. Head Neck. 2016; 38(9):1347-53. DOI: 10.1002/hed.24441. View

10.

Richards T, Bhide S, Miah A, Del Rosario L, Bodla S, Thway K . Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies. Clin Oncol (R Coll Radiol). 2016; 28(9):e77-e84. DOI: 10.1016/j.clon.2016.04.035. View

11.

Al Kadah B, Papaspyrou G, Linxweiler M, Schick B, Rube C, Buchler B . Cancer of unknown primary (CUP) of the head and neck: retrospective analysis of 81 patients. Eur Arch Otorhinolaryngol. 2017; 274(6):2557-2566. DOI: 10.1007/s00405-017-4525-8. View

12.

Fakhrian K, Thamm R, Knapp S, Molls M, Pigorsch S, Haller B . Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis. Strahlenther Onkol. 2011; 188(1):56-61. DOI: 10.1007/s00066-011-0017-8. View

13.

Strojan P, Ferlito A, Langendijk J, Corry J, Woolgar J, Rinaldo A . Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head Neck. 2011; 35(2):286-93. DOI: 10.1002/hed.21899. View

14.

Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre J, Greiner R . Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004; 350(19):1945-52. DOI: 10.1056/NEJMoa032641. View

15.

Bernier J, Cooper J, Pajak T, Van Glabbeke M, Bourhis J, Forastiere A . Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005; 27(10):843-50. DOI: 10.1002/hed.20279. View

16.

Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S . Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol. 2012; 104(3):343-8. DOI: 10.1016/j.radonc.2012.07.001. View

17.

Waltonen J, Ozer E, Hall N, Schuller D, Agrawal A . Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup. Arch Otolaryngol Head Neck Surg. 2009; 135(10):1024-9. DOI: 10.1001/archoto.2009.145. View

18.

Nguyen T, Nguyen E, Warner A, Louie A, Palma D . Failed Randomized Clinical Trials in Radiation Oncology: What Can We Learn?. Int J Radiat Oncol Biol Phys. 2018; 101(5):1018-1024. DOI: 10.1016/j.ijrobp.2018.04.030. View

19.

Lee T, Fang F . Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy. Radiother Oncol. 2013; 106(3):352-8. DOI: 10.1016/j.radonc.2012.11.013. View

20.

Kwee T, Kwee R . Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol. 2008; 19(3):731-44. PMC: 2816234. DOI: 10.1007/s00330-008-1194-4. View